Skip to content
Biodatica
Start free

Investigator

Terry L. Sheppard

KEYSTONE SYMPOSIA · funded by NINDS, NCI, NIAID

Companies
3

Resolved onto their grants.

Grants
19

Federal awards on file.

Non-dilutive funding
$258k

Summed across those awards.

First award
Jan 3, 2025

Latest Jun 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R13

    Neurodegeneration: From Neurocentric to System-Wide Perspectives

    $9k

    Jun 1, 2026NINDSKEYSTONE SYMPOSIANIH RePORTER · 11392034 (opens the source filing in a new tab)

  2. R13

    Tumor Microenvironment: Identifying Drivers of Progression and Resistance

    $5k

    May 1, 2026NCIKEYSTONE SYMPOSIANIH RePORTER · 11392747 (opens the source filing in a new tab)

  3. R13

    Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations

    $5k

    Mar 3, 2026NCIKEYSTONE SYMPOSIANIH RePORTER · 11321075 (opens the source filing in a new tab)

  4. R13

    RNA Modifications: Bridging Biological Function and Therapeutic Potential

    $10k

    Mar 3, 2026NCIKEYSTONE SYMPOSIANIH RePORTER · 11320647 (opens the source filing in a new tab)

  5. R13

    B Cells and Plasma Cells: Fundamental and Translational Biology

    $16k

    Feb 25, 2026NIAIDKEYSTONE SYMPOSIANIH RePORTER · 11321066 (opens the source filing in a new tab)

  6. R13

    B and T Cell Collaboration in Lymphoid and Nonlymphoid Microenvironments

    $14k

    Feb 25, 2026NIAIDKEYSTONE SYMPOSIANIH RePORTER · 11321073 (opens the source filing in a new tab)

  7. R13

    Myeloid Cells: Functional Heterogeneity with Therapeutic Promise

    $17k

    Feb 10, 2026NIAIDKEYSTONE SYMPOSIANIH RePORTER · 11321056 (opens the source filing in a new tab)

  8. R13

    Mitochondria Signaling in Physiology and Disease

    $21k

    Feb 5, 2026NINDSKEYSTONE SYMPOSIANIH RePORTER · 11320593 (opens the source filing in a new tab)

  9. R13

    Hematopoiesis

    $12k

    Feb 1, 2026NHLBIKEYSTONE SYMPOSIANIH RePORTER · 11321049 (opens the source filing in a new tab)

  10. R13

    Aging: Immune Function and Organ Health

    $20k

    Feb 1, 2026NIAKEYSTONE SYMPOSIANIH RePORTER · 11321126 (opens the source filing in a new tab)

  11. R13

    Cardiometabolism in Health and Disease

    $18k

    Jan 21, 2026NHLBIKEYSTONE SYMPOSIANIH RePORTER · 11320687 (opens the source filing in a new tab)

  12. R13

    iPSCs: Progress, Opportunities, and Challenges

    $18k

    Jan 20, 2026NCATSKEYSTONE SYMPOSIANIH RePORTER · 11320460 (opens the source filing in a new tab)

  13. R13

    Spotlight on the Cancer Cell: Intrinsic Properties and Vulnerabilities for Therapeutics

    $20k

    Aug 6, 2025NCIKEYSTONE SYMPOSIANIH RePORTER · 11247281 (opens the source filing in a new tab)

  14. R13

    Organoids: Engineering Innovative Approaches for Basic and Translational Insight

    $10k

    Apr 18, 2025NICHDKEYSTONE SYMPOSIANIH RePORTER · 11165647 (opens the source filing in a new tab)

  15. R13

    Human Microbiome: Diversity, Selection and Adaptation

    $18k

    Feb 1, 2025NIDDKKEYSTONE SYMPOSIANIH RePORTER · 11071660 (opens the source filing in a new tab)

  16. R13

    Malaria: Mechanisms of Immunity & Protection

    $8k

    Jan 23, 2025NIAIDKEYSTONE SYMPOSIANIH RePORTER · 11166215 (opens the source filing in a new tab)

  17. R13

    Tuberculosis: Heterogeneity from Experimental Models to Human Disease

    $7k

    Jan 23, 2025NIAIDKEYSTONE SYMPOSIANIH RePORTER · 11072739 (opens the source filing in a new tab)

  18. R13

    MASH Pathogenesis and Therapeutic Approaches

    $17k

    Jan 8, 2025NIDDKKEYSTONE SYMPOSIANIH RePORTER · 11071843 (opens the source filing in a new tab)

  19. R13

    Drug Delivery to the Brain: Emerging Modalities

    $15k

    Jan 3, 2025NINDSKEYSTONE SYMPOSIANIH RePORTER · 11074359 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources